Acorai

Built on Acorai’s proprietary datasets and data partnerships with world-leading hospitals. The Acorai Heart Monitor has been designed to offer accurate, personalized, and efficient care for heart failure patients. The objective of the Acorai Heart Monitor is to offer accurate estimations of pulmonary pressure to support personalized heart failure treatment. Ongoing clinical validation to provide continuous and actionable information to support decision-making across all stages of heart failure. The Save Sensor System is a first-of-its-kind hardware architecture and machine learning with absolute intracardiac insights in mind. An ongoing clinical study (CAPTURE-HF) aims to confirm if the monitor can deliver actionable information equal to invasive methods. Ensuring that patients are stable prior to discharge reduced reamission rates. EIC invests in companies with innovative, game-changing products, services or business models that could create new markets or disrupt existing ones.